Clinical Trial Update: Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rituximab maintenance therapy to observation in chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED